Vaccination News Home Page

http://www.blackwell-synergy.com/servlet/useragent?func=synergy&synergyAction=showAbstract&doi=10.1046/j.1440-1754.2002.00035.x

image Home image Browse image Search image My Synergy image Register image Help image
image
 
Username
Password
you are at...
image
image
image image
image

 

 

Abstract
 

Journal of Paediatrics and Child Health
Volume 38 Issue 5 Page 445  - October 2002

 
Childhood invasive pneumococcal disease in Tasmania, 1994-2000
DJF Christie1 DJ Coleman2 X Wan2 MA Jacobs2 and JR Carapetis3
Objective: To describe the burden of invasive pneumococcal disease in Tasmanian children, including age-specific incidence and antibiotic-resistance pattern.

Methods: A population-based retrospective study was carried out, examining cases of childhood disease associated with isolates of Streptococcus pneumoniae from normally sterile sites, identified via scrutiny of laboratory records at all major Tasmanian laboratories during a 7-year period between January 1994 and December 2000. Medical records were sub­sequently examined for information describing the clinical syndrome and course of disease.

Results: Invasive pneumococcal disease was identified in 76 children during the 7-year period. The incidence per 100 000 children was 28.5 (95% CI 22.0-36.3) in children under 5 years and 54.3 (95% CI 40.2-71.8) in children under 2 years. The incidence of meningitis in children younger than 2 years was 12.2 (95% CI 6.1-21.8). Penicillin resistance was observed in 2.6% of cases, with no high level resistance. Predisposing conditions were identified in 34% of children with invasive disease.

Conclusions: The incidence of invasive pneumococcal disease was comparable to many urban populations in Australia. The high rate of predisposing conditions supports the recommendations of the Australian Technical Advisory Group on Immunisation for targeted immunization in this group. The paucity of data describing Indigenous status is an argument for improved data collection in this area. The low level of penicillin resistance necessitates ongoing surveillance, and the lack of serotype information requires prospective data collection.

 
Access Full Article HTML    Access Full Article PDF
 
List of Issues
image
Table of Contents
image
Previous Article Next Article
image
Add to Favorites
image
Email to a Friend
image
Jacket

for
Authors:
DJF Christie
DJ Coleman
X Wan
MA Jacobs
JR Carapetis
age-specific incidence
antibiotic resistance
Streptococcus pneumoniae
surveillance

 

1Department of Paediatrics, Royal Hobart Hospital, 2Public and Environmental Health Service, Department of Health and Human Services, Hobart, Tasmania and 3Centre for International Child Health, Department of Paediatrics, University of Melbourne, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia

 
Correspondence: Mr DJ Coleman, Public and Environmental Health Service, Department of Health and Human Services, Hobart, Tas. 7000, Australia. Fax: +61 3 6233 6620; email: david.coleman@dhhs.tas.gov.au
To cite this article
Christie, DJF, Coleman, DJ, Wan, X, Jacobs, MA & Carapetis, JR
Childhood invasive pneumococcal disease in Tasmania, 1994-2000.
Journal of Paediatrics and Child Health 38 (5), 445-449.
doi: 10.1046/
j.1440-1754.2002.00035.x

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.